Sapio Sciences has licensed its Exemplar LIMS product to one of the top five pharmaceutical companies in the world, to help organise its genetics research.
The pharma company currently produces thousands of samples, which could soon grow into millions in the near future. The software provides straightforward wizards to handle the samples automatically, which may then be tracked using 1D and 2D barcodes. The built in reagent protocols for Illumina and Affymetrix platforms eliminate the need for paper tracking of lab procedures.
If this approach seems to be verging on the ELN market, it was wholly deliberate, according to Kevin Cramer, CEO at Sapio, who says the product also integrates bioinformatics systems. ‘We felt from the beginning that intuitively all these product categories should really be one product. In fact, we are going to extend that definition even further to say that certain analytics results and even clinical trial management should be part of a complete LIMS solution.’
The Exemplar LIMS BioBanking module helps the laboratories of the company, whose name has not been disclosed, to adhere to Good Laboratory Practices regulations and FDA CFP 11 Part 21 patent regulations.
